PH12102A - 2,1,3-benzothiadiazole as myotonolytics - Google Patents

2,1,3-benzothiadiazole as myotonolytics

Info

Publication number
PH12102A
PH12102A PH18696A PH18696A PH12102A PH 12102 A PH12102 A PH 12102A PH 18696 A PH18696 A PH 18696A PH 18696 A PH18696 A PH 18696A PH 12102 A PH12102 A PH 12102A
Authority
PH
Philippines
Prior art keywords
myotonolytics
benzothiadiazole
Prior art date
Application number
PH18696A
Other languages
English (en)
Inventor
E Eichenberger
P Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH12102A publication Critical patent/PH12102A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH18696A 1975-07-28 1976-07-16 2,1,3-benzothiadiazole as myotonolytics PH12102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31585/75A GB1559811A (en) 1975-07-28 1975-07-28 Pharmaceutically active benzothiadiazole derivatives

Publications (1)

Publication Number Publication Date
PH12102A true PH12102A (en) 1978-11-02

Family

ID=10325329

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18696A PH12102A (en) 1975-07-28 1976-07-16 2,1,3-benzothiadiazole as myotonolytics

Country Status (14)

Country Link
US (1) US4053617A (xx)
JP (1) JPS5215826A (xx)
AU (1) AU514478B2 (xx)
BE (1) BE844532A (xx)
CA (1) CA1069441A (xx)
GB (1) GB1559811A (xx)
HK (1) HK11183A (xx)
IE (1) IE44427B1 (xx)
IL (1) IL50127A0 (xx)
MY (1) MY8400086A (xx)
NZ (1) NZ181572A (xx)
PH (1) PH12102A (xx)
SG (1) SG64182G (xx)
ZA (1) ZA764535B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPH0378003U (xx) * 1989-11-28 1991-08-07
US20040220240A1 (en) * 2001-11-28 2004-11-04 Pellegrini Cara A. Method of increasing the extent of absorption of tizanidine
US6455557B1 (en) 2001-11-28 2002-09-24 Elan Pharmaceuticals, Inc. Method of reducing somnolence in patients treated with tizanidine
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
DE10229370A1 (de) * 2002-06-29 2004-01-15 Covion Organic Semiconductors Gmbh 2,1,3-Benzothiadiazole
MXPA05005038A (es) * 2002-11-12 2005-07-01 Teva Pharma Composiciones farmaceuticas y formas de dosis para la entrega bucal y sublingual de tizanidina y metodos para administrar tizanidina sublingual o bucalmente.
WO2008008394A1 (en) * 2006-07-12 2008-01-17 Transform Pharmaceuticals, Inc. Tizanidine succinate salt forms and methods of making and using the same
WO2008027419A2 (en) * 2006-08-31 2008-03-06 Transform Pharmaceuticals, Inc. Tizanidine sulfate salt forms and methods of making and using the same
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (xx) * 1972-05-09 1975-12-15 Wander Ag Dr A

Also Published As

Publication number Publication date
IL50127A0 (en) 1976-09-30
NZ181572A (en) 1978-06-02
CA1069441A (en) 1980-01-08
JPS5215826A (en) 1977-02-05
HK11183A (en) 1983-03-24
AU1629376A (en) 1978-02-02
IE44427B1 (en) 1981-12-02
JPS6133803B2 (xx) 1986-08-04
SG64182G (en) 1983-09-16
ZA764535B (en) 1978-03-29
US4053617A (en) 1977-10-11
MY8400086A (en) 1984-12-31
GB1559811A (en) 1980-01-30
AU514478B2 (en) 1981-02-12
BE844532A (fr) 1977-01-26
IE44427L (en) 1977-01-28

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
PH12102A (en) 2,1,3-benzothiadiazole as myotonolytics
NZ183651A (en) Tribalo-n-alkyl-2',4',6'-trinitrodiphenylamines
GB1532697A (en) 2,3-dihydroergolines
PH14168A (en) 2,4-pyrrolidinediones
GB1557694A (en) 2,9 dichlorquinacridone
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1550440A (en) 1,3,4-oxadiazole derivatives
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
GB1554021A (en) 4,5-didehydroprostaglandins
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
EG12183A (en) 2-chloro-n-isoproyl-2',3'-imethylacetanilide
IE43710L (en) 1,2,4-thiadiazole derivatives
GB1543807A (en) 1,2,3,4,6,7,12,12b-octahydro-1,12-methanooxymethano-indolo(2,3-o)quinolizines
GB1554925A (en) 2,3-methyl-eneprostaglandins
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
NZ181037A (en) 6-heteroaryl-3-substituted-3,4-dihydro-2h-1,3,5-oxadiazin-2-ones
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1483576A (en) 16,16-dimethyl-prostaglandins
PH15282A (en) 1,2-dihydro-6-phenyl-1h-imidazo-benzodiazepin-1-ones
GB1541079A (en) 2-heterocyclylalkyl-3,3a,4,5,6,7-hexa hydro-3-phenyl-7-benzylidene-2h-indazoles
AU1346176A (en) 1,2,3,4-tetrahydro-4-oxo-%or-oxy-<-1-naphthylureas
GB1551409A (en) 3,5-diphenylpyridazine derivatives